Finanzen von Innoviva Inc (INVA)INVAInnoviva Inc

Evaluating the bottom line, Innoviva, Inc. maintains a gross margin of 75.77%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 42.52%, while the net margin is -69.75%. These profitability ratios, combined with a Return on Equity (ROE) of 36.68%, provide a clear picture of how effectively INVA converts its operational activities into shareholder value.

In the context of the broader market, INVA competes directly with industry leaders such as GPCR and PCRX. With a market capitalization of $1.52B, it holds a leading position in the sector. When comparing efficiency, INVA's gross margin of 75.77% stands against GPCR's N/A and PCRX's 69.60%. Such benchmarking helps identify whether Innoviva, Inc. is trading at a premium or discount relative to its financial performance.

Innoviva's revenue for Q2 2026 was $119.6 million, showing a strong year-over-year growth, but it reported a net loss of $83.4 million, which raises concerns about its profitability.